Park Ha Biological Technology Finalizes 1-for-50 Reverse Stock Split Details, Effective February 20
BYAH is trading near its 52-week low of $0.055 (13% above the low) on light trading volume (0.1× avg).
Summary
Park Ha Biological Technology Co., Ltd. has provided final details regarding its 1-for-50 reverse stock split, including pre- and post-split share counts, effective February 20, 2026.
Key Events · Corporate Governance and Compliance · BYAH
-
Reverse Stock Split Finalized
The company has finalized the terms for a 1-for-50 reverse stock split, previously announced on February 10, 2026.
-
Effective Date Confirmed
The reverse stock split is expected to become effective on February 20, 2026, with trading on a split-adjusted basis commencing at market open on that day.
-
Share Capital Adjustment Details
Pre-split, the company had 104,768,362 ordinary shares outstanding. Post-split, this will be adjusted to 2,095,368 ordinary shares, with fractional shares rounded up.
Analysis · BYAH · Industrial Applications And Services
This filing provides the definitive details for Park Ha Biological Technology's previously announced 1-for-50 reverse stock split, confirming the effective date and outlining the adjusted share capital. For a company with a very low stock price, a reverse split is often a necessary measure to meet exchange listing requirements, such as Nasdaq's minimum bid price. While it does not change the company's underlying value, it is a critical step for maintaining its public listing and can be perceived negatively by investors as it often signals financial distress or a need to avoid delisting.
At the time of this filing, BYAH was trading at $0.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $0.05 to $41.49. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.